Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2025-11-12 00:00:00 ET · period of report 2025-11-10 · accession 0001673232-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMTI | 2025-11-12 | 2025-11-10 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $139.13 | -6,750 | 7,875 | -46% | -$939.2K |
| DMTI | 2025-11-12 | 2025-11-10 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $452.07 | -22.5K | 0 | -100% | -$10.17M |
| DMTI | 2025-11-12 | 2025-11-10 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $0.00 | -22.5K | 2,625 | -90% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-10 | M | D | 14,625 | $135.42 | 14,625 | I by Trust | — | — | (F2) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. |
| 2 | Common | Common Stock | 2025-11-10 | S | D | 14,625 | $452.09 | 0 | I by Trust | — | — | (F2) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. |
| 3 | Common | Common Stock | 2025-11-10 | M | A | 7,875 | $146.03 | 7,875 | I by Trust | — | — | (F3) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. |
| 4 | Common | Common Stock | 2025-11-10 | S | D | 7,875 | $452.04 | 0 | I by Trust | — | — | (F3) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. |
| 5 | Derivative | Stock Options | 2025-11-10 | M | D | 14,625 | $0.00 | 26,625 | I by Trust | $135.42 · 2023-03-15 to 2026-03-15 | 14,625 Common Stock | (F2) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. |
| 6 | Derivative | Stock Options | 2025-11-10 | M | D | 7,875 | $0.00 | 2,625 | I by Trust | $146.03 · 2023-03-15 to 2026-03-15 | 7,875 Common Stock | (F3) Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. |